The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor

BACKGROUND AND PURPOSE: Immunotherapy has shown great efficacy in many cancers, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unclear. The objective of this study was to investigate the impact of immunotherapy on the overall survival of PDAC patients who did not receive definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Saber, Baine, Michael, Meza, Jane, Alam, Morshed, Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317682/
https://www.ncbi.nlm.nih.gov/pubmed/32613090
http://dx.doi.org/10.1016/j.ctro.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317682/
https://www.ncbi.nlm.nih.gov/pubmed/32613090
http://dx.doi.org/10.1016/j.ctro.2020.06.003

Ejemplares similares